News

Peter Hamer joins SurgaColl as Chief Executive Officer

Alderley Park, UK – 10th December 2018. SurgaColl, a regenerative medicine company, today announced the appointment of Peter Hamer as Chief Executive Officer. Mr. Hamer succeeds Bill Allan as CEO following Bill’s decision to retir...

Maxwellia expand their team with two new appointments

Maxwellia has expanded their team of switch experts with two new appointments following their relocation to the Alderley Park Accelerator.  Maxwellia, the UK’s only ‘prescription to over the counter (OTC)’ medicines company...

Med-Tech companies triumph at the Bionow Awards

The outstanding companies and leaders of the North’s life sciences sector – which is worth more than £13bn to the economy- were honoured last night at the 17th annual Bionow Awards. More than 300 people attended the awards d...

Blueberry Therapeutics Announce Positive Results from a Phase I-II Clinical Trial

Alderley Park, UK, 21stNovember 2018– Blueberry Therapeutics Limited (“Blueberry Therapeutics”), a modern drug discovery and development company committed to the development of innovative new therapies for the treatment of common...

YProtech receives £400k funding boost

A high value chemistry services company based at Alderley Science Park has secured £400,000 of funding. YProtech (YPT) was founded in 2011. The core of the company's business relates to those operating in the pharmaceutical, biotechnolo...

From our portfolio

metaLinear

Biotechnology

viewview our portfolio

Our Team

Corinne Lawrence

view complete team

Contact us

Alderley Park
Alderley Edge
Cheshire
SK10 4TG

Tel: 01625 344300

email